VICTOR: Vinflunine in advanced metastatic transitional cell carcinoma of the urothelium: A retrospective analysis of the use of vinflunine in multi-centre real life setting as second line chemotherapy through Free of Charge Programme for patients in the UK and Ireland

There is no standard of care in the UK or Ireland for second-line chemotherapy for patients with advanced transitional cell carcinoma (TCCU). Vinflunine is approved for TCCU patients who have failed a platinum-based regimen, and is standard of care in Europe but is not routinely available in the UK....

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain, Syed A., Ansari, Jawaher, Huddart, Robert, Power, Derek G., Lyons, Jeanette, Wylie, James, Vilarino-Varlela, Maria, Elander, Nils O., McMenemin, Rhona, Pickering, Lisa M., Faust, Guy, Chauhan, Seema, Jackson, Richard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358710/
https://www.ncbi.nlm.nih.gov/pubmed/28098864
http://dx.doi.org/10.3892/ijo.2017.3847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358710/
https://www.ncbi.nlm.nih.gov/pubmed/28098864
http://dx.doi.org/10.3892/ijo.2017.3847

Ejemplares similares